4 results
To determine the safety and efficacy of coversin in the treatment of patients with PNH resistant to eculizumab.
To demonstrate non-inferiority of a T2T strategy in which conventional synthetic disease modifying drugs (csDMARDs) refractory RApatients are initially treated with tsDMARD baricitinib versus the comparable T2T strategy in which patients are…
* The purpose of this study is to to determine the safety profile of long-termCoversin treatment.* To observe the long term safety and efficacy of Coversin over periods in excess of 6 months* To assess the long term patient acceptability of Coversin…
The aim of the current study is to assess the feasibility, safety and efficacy of the Steam ablation System for eradication of small BE areas